Pfizer-BioNTech files for U.S. approval of COVID-19 vaccine

Pfizer-BioNTech files for U.S. approval of COVID-19 vaccine

Pfizer and German partner BioNTech have filed for a full U.S. approval for their COVID-19 vaccine, which is now authorized only for emergency use, the drugmakers said on Friday.


Share:

Comments

Comentarios de Facebook